| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4289774
Max Phase: Preclinical
Molecular Formula: C16H15N3O4S
Molecular Weight: 345.38
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)NC1=NN(C(C)=O)C(C)(c2cc3ccccc3oc2=O)S1
Standard InChI: InChI=1S/C16H15N3O4S/c1-9(20)17-15-18-19(10(2)21)16(3,24-15)12-8-11-6-4-5-7-13(11)23-14(12)22/h4-8H,1-3H3,(H,17,18,20)
Standard InChI Key: ZPGQKVJOZMLKOH-UHFFFAOYSA-N
Associated Targets(Human)
Kinesin-like protein 1 1720 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 345.38 | Molecular Weight (Monoisotopic): 345.0783 | AlogP: 1.97 | #Rotatable Bonds: 1 |
| Polar Surface Area: 91.98 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 10.68 | CX Basic pKa: | CX LogP: 1.49 | CX LogD: 1.49 |
| Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.80 | Np Likeness Score: -0.31 |
References
| 1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |
Source
Source(1):